| 图片 | 名称及描述 | |
|---|---|---|
|
α-L-Talofuranuronamide, 1-deoxy-5-O-(4-deoxy-6-phenyl-β-L-erythro-hex-4-enopyranuronosyl)-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)
97%
|
|
|
α-L-Talofuranuronamide, 1-deoxy-5-O-(4-deoxy-N-2-quinolinyl-β-L-erythro-hex-4-enopyranuronamidosyl)-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)
97%
|
|
|
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-(2,2-diethoxyethyl)-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)
97%
|
|
|
α-L-Talofuranuronamide, 1-deoxy-5-O-(4-deoxy-N-hexadecyl-β-L-erythro-hex-4-enopyranuronamidosyl)-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)
97%
|
|
|
α-L-Talofuranuronamide, 1-deoxy-5-O-(4-deoxy-N-undecyl-β-L-erythro-hex-4-enopyranuronamidosyl)-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)
97%
|
|
|
α-L-Talofuranuronamide, 1-deoxy-5-O-(4-deoxy-N-nonyl-β-L-erythro-hex-4-enopyranuronamidosyl)-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)
97%
|
|
|
α-L-Talofuranuronamide, 1-deoxy-5-O-(4-deoxy-N-propyl-β-L-erythro-hex-4-enopyranuronamidosyl)-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)
97%
|
|
|
α-L-Talofuranuronamide, 1-deoxy-5-O-[2,3-di-O-acetyl-4-deoxy-N-[(3S)-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-acetate (ACI)
97%
|
|
|
α-L-Talofuranuronamide, 1-deoxy-1-[3,4-dihydro-2,4-dioxo-3-[(phenylmethoxy)methyl]-1(2H)-pyrimidinyl]-3-O-methyl-5-O-(2,3,4-tri-O-acetyl-α-D-mannopyranosyl)-, 2-acetate (ACI)
97%
|
|
|
α-L-Talofuranuronamide, 1-deoxy-5-O-[4,6-dideoxy-6-oxo-6-(1-pyrrolidinyl)-β-L-erythro-hex-4-enopyranosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)
97%
|
|
|
α-L-Talofuranuronamide, 1-deoxy-5-O-(4-deoxy-β-L-erythro-hex-4-enopyranuronosyl)-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)- (9CI)
97%
|
|
|
α-L-Talofuranuronamide, 1-deoxy-5-O-(2,3-di-O-acetyl-4-deoxy-N-phenyl-β-L-erythro-hex-4-enopyranuronamidosyl)-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-acetate (9CI)
97%
|
|
|
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-(2-ethylhexyl)-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)
97%
|
|
|
α-L-Talofuranuronamide, 1-deoxy-5-O-(4-deoxy-β-L-erythro-hex-4-enopyranuronamidosyl)-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)
97%
|
|
|
α-L-Talofuranuronamide, 1-[3-[1-[[(cyclohexyloxy)carbonyl]oxy]ethyl]-3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl]-1-deoxy-5-O-[4-deoxy-N-(3,4-difluorophenyl)-2,3-O-(1-methylethylidene)-β-L-erythro-hex-4-enopyranuronamidosyl]-3-O-methyl- (9CI)
97%
|
|
|
α-L-Talofuranuronamide, 1-[3-[1-[[(cyclohexyloxy)carbonyl]oxy]ethyl]-3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl]-1-deoxy-5-O-[4-deoxy-N-(3,4-difluorophenyl)-2,3-O-(1-methylethylidene)-β-L-erythro-hex-4-enopyranuronamidosyl]-2-O-[(1,1-dimethylethyl)dimethylsilyl]-3-O-methyl- (9CI)
97%
|
|
|
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-2,3-O-(1-methylethylidene)-N-phenyl-β-L-erythro-hex-4-enopyranuronamidosyl]-1-[3-[(2,2-dimethyl-1-oxopropoxy)methyl]-3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl]-3-O-methyl- (9CI)
97%
|
|
|
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-2,3-O-(1-methylethylidene)-N-phenyl-β-L-erythro-hex-4-enopyranuronamidosyl]-2-O-[(1,1-dimethylethyl)dimethylsilyl]-1-[3-[(2,2-dimethyl-1-oxopropoxy)methyl]-3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl]-3-O-methyl- (9CI)
97%
|
|
|
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-2,3-O-(1-methylethylidene)-N-phenyl-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-2-O-[(1,1-dimethylethyl)dimethylsilyl]-3-O-methyl- (9CI)
97%
|
|
|
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-2,3-O-(1-methylethylidene)-N-(4-pentylphenyl)-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-(O-phenyl carbonothioate) (9CI)
97%
|
0086-571-89925085
